Valuation: Karex

Market Cap 464M 114M 100M 94.77M 85.56M 161M 10.89B 163M 1.13B 436M 5.57B 427M 417M 17.85B P/E 2026
1,600x
P/E 2027 * 24.4x
Enterprise Value 464M 114M 100M 94.77M 85.56M 161M 10.89B 163M 1.13B 436M 5.57B 427M 417M 17.85B EV / Sales 2026
1.09x
EV / Sales 2027 * 0.9x
Free-Float
39.68%
Yield 2026
2.08%
Yield 2027 * 2.12%
1 week-1.12%
1 month-9.28%
3 months-8.33%
6 months-12.00%
Current year-37.59%
1 week 0.44
Extreme 0.44
0.45
1 month 0.44
Extreme 0.44
0.49
Current year 0.43
Extreme 0.43
0.73
1 year 0.43
Extreme 0.43
1.05
3 years 0.43
Extreme 0.43
1.09
5 years 0.32
Extreme 0.325
1.09
10 years 0.26
Extreme 0.26
2.62
Manager TitleAgeSince
Chief Executive Officer 48 28/07/2013
Director of Finance/CFO 49 29/06/2025
Chief Tech/Sci/R&D Officer 71 26/09/2012
Director TitleAgeSince
Director/Board Member 71 26/09/2012
Director/Board Member 83 29/11/2012
Director/Board Member 48 24/02/2020
Date Insider Type Main position Quantity % Market Cap. Importance
16/07/26 Free

Director

80,000 0.0076%
16/07/26 Free

Chief Technology Officer

80,000 0.0076%
16/07/26 Free

Chief Executive Officer

80,000 0.0076%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.12%-45.34%-21.43% 114M
-1.08%-1.07%-5.92%-0.74% 337B
-2.54%-3.80%+1.01%-6.01% 229B
-2.93%-4.60%-8.67%-0.79% 132B
-1.10%-0.33%+7.63%+20.18% 68.01B
-2.68%0.00%+20.45% - 46.35B
-2.29%-5.04%-27.61%-25.63% 46.05B
-2.41%-1.05%+9.94%-14.25% 33.92B
-3.89%-5.44%+4.62%-37.11% 33.56B
-3.06%-1.59%-22.36%-19.61% 32.4B
Average -2.12%-1.18%-6.62%-11.71% 95.89B
Weighted average by Cap. -1.94%-1.08%-3.07%-4.28%

Financials

2026 2027 *
Net sales 483M 118M 104M 98.71M 89.12M 168M 11.34B 170M 1.18B 454M 5.8B 444M 435M 18.59B 515M 126M 111M 105M 95.09M 179M 12.1B 182M 1.26B 485M 6.19B 474M 464M 19.84B
Net income -5.82M -1.43M -1.26M -1.19M -1.07M -2.02M -137M -2.05M -14.24M -5.48M -69.91M -5.36M -5.24M -224M 19.2M 4.71M 4.14M 3.93M 3.54M 6.68M 451M 6.77M 46.97M 18.07M 231M 17.67M 17.28M 739M
Net Debt - -
Logo Karex
Karex Berhad is a Malaysia-based investment holding company. The Company has three segments. Sexual Wellness segment is engaged in the sale of condoms, personal lubricants and sex toys. Medical segment is engaged in the sale of catheters, probe covers, human immunodeficiency virus (HIV) and pregnancy test kits, and other medical related products. Other segment is engaged in the sale of products not related to sexual wellness and medical. Its subsidiaries, including Hevea Medical Sdn. Bhd., Innolatex Sdn. Bhd., Innolatex (Thailand) Limited, Karex Industries Sdn. Bhd. and Medical-Latex (Dua) Sdn. Bhd. are engaged in the manufacturing and selling of condoms, rubber products, personal lubricants, and others. Its subsidiary, Karex Marketing Sdn. Bhd. engages in manufacturing and selling hand sanitizers, condoms, personal lubricants, and others. Its subsidiaries, Karex Global Limited, Karex Holdings Sdn. Bhd., Karex International Sdn. Bhd. are engaged in investment holding activity.
Employees
3,061
Date Price Change Volume
01/10/26 MYR 0.4400 0.00% 138,500
30/09/26 MYR 0.4400 -2.22% 120,900
29/09/26 MYR 0.4500 +2.27% 284,300
28/09/26 MYR 0.4400 -2.22% 230,500
25/09/26 MYR 0.4500 +2.27% 105,600
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.4400MYR
Average target price
0.5833MYR
Spread / Average Target
+32.58%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 5247 Stock